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INTRODUCTION
Brain is separated from the systemic circulation by two barriers: a blood-brain barrier (BBB) and a blood-cerebrospinal-fluid barrier (BCSFB). The BBB and BCSFB represent physical and enzymatic barriers to restrict and regulate the penetration of compounds into and out of the brain and maintain the homeostasis of the brain microenvironment (Davson and Segal, 1995) .
Brain penetration is essential for compounds where the site of action is within the central nervous system (CNS). For targets outside the CNS, BBB penetration may need to be minimized to reduce CNS-related side effects (Chen et al., 2003) .
The brain-to-plasma concentration ratio (K p ) is the most commonly used parameter for measuring brain penetration in a drug discovery setting. A large K p is considered a favorable property of a good CNS compound. This approach implies that a compound having a high K p penetrates into brain tissue better than one having a low K p . However, according to the definition of K p (K p = C brain /C plasma ) and unbound fraction in plasma (f u,plasma =C u,plasma /C plasma ) and brain (f u,brain = C u,brain /C brain ) the following equation can be obtained: K p,in , defined as the ratio of f u,plasma over f u,brain , can be considered the "intrinsic" partition coefficient between brain and plasma. It is determined by nonspecific binding in brain and plasma and is not related to BBB properties. K p,free , defined as the ratio of the free brain concentration (C u,brain ) over the free plasma concentration (C u,plasma ), delineates BBB properties and governs the relationship between free brain and plasma concentrations. K p,free represents a better parameter than K p to assess brain penetration or brain bioavailability for CNS compounds .
However, it is difficult to determine K p,free experimentally. As a surrogate approach in drug discovery, K p is often used to select compounds with good brain penetration. However, using K p introduces the caveat that a high K p can be due to a high K p,in or K p,free and a low K p can be due to a low K p,in or K p,free . Therefore, when K p is used to select CNS compounds, it is critical to ensure that a low K p is due to a low K p,free but not due to a low K p,in . In order to overcome the limitation of K p , we propose determining K p,in and then indirectly evaluating K p,free using Equation 1. 5 K p,in may be calculated from f u,plasma and f u,brain , which can be determined using in vitro approaches, such as equilibrium dialysis, ultrafiltration and ultracentrifugation from plasma and brain tissue homogenate (Fichtl et al., 1991; Kalvass and Maurer, 2002; Maurer et al., 2005) .
Recently, Maurer et al. (2005) demonstrated that nonspecific binding in brain homogenate and plasma can be used to predict in vivo K p for 23 of 33 tested compounds within a 3-fold range. The concern of estimating f u,brain from brain homogenate is that brain homogenization may change brain binding properties by unmasking binding sites that are not normally accessible to a drug in vivo. In addition, the unbound fraction in brain tissue may not be directly extrapolated from the unbound fraction determined from diluted brain tissue homogenate.
Brain slices have been used to study neural physiology for almost half a century (Collinridge, 1994) Cellular structure is maintained in slices but the blood-brain barrier is not functional since a compound can directly penetrate into the brain slices from the incubation medium (Newman et al., 1988) . The use of brain slices to estimate the f u,brain has been reported in the literature (Van Peer et al., 1981) . In that study, 1000 µm brain slices were incubated for one hour and the buffer-to-slice ratio was assumed to be equal to the in vivo f u,brain . Brain slices have also been used to study the partition coefficient between slice and incubation buffer (Ooie et al., 1997; Gredell et al., 2004) . Based on the same concept, Kakee et al. (1996) used brain slices to estimate the apparent distribution volume in brain. Our main concern was that diffusion into brain tissue may be time dependent and whether one hour was sufficient time for the 1000 µm brain slices to reach equilibrium. No extensive validation study was reported for the brain slice method.
In the present study, the experimental conditions for a brain slice uptake study and the utility of brain slices to determine K p,in are evaluated.
This article has not been copyedited and formatted. The final version may differ from this version. Animal Experiments. Male FVB (wild type) and mdr1a/1b (-/-,-/-) mice (20-30 g) were obtained from Taconic (Germantown, NY). All animals were housed in a controlled temperature and humidity environment with an alternating 12-hour light and dark cycle with free access to food and water.
Mice received a 10 mg/kg subcutaneous dose of NFPS, propranolol, theobromine, or theophylline. The doses were prepared in 0.9% saline and delivered in a volume of 2 mL/kg. Animals were sacrificed in a CO 2 chamber. Blood samples were collected in heparin treated tubes at designated times between 10 minutes and 24 hours via cardiac puncture. After centrifugation (3000 rpm, 10 min) of the blood, plasma was isolated. Brain tissue was harvested and rinsed with saline immediately after collection. The plasma and brain samples were stored at -20°C prior to analysis.
Protein Binding. The unbound fraction in plasma and brain homogenate was determined using a 96-well equilibrium dialysis method reported previously (Kalvass and Maurer, 2002) . Briefly, Sprague-Dawley rat plasma and brain tissue were obtained on the day of the study. Brain tissue was homogenized in two volumes (w/v) of 100 mM sodium phosphate buffer.
Plasma, brain homogenate, and phosphate buffer (for equilibrium controls) were adjusted to pH 7.4 and then spiked with compound (500 ng/mL) and 150 µL of the spiked matrix was added to individual wells of the dialysis apparatus. The receiver side contained 150 µL of phosphate buffer. The 96-well equilibrium dialysis apparatus was maintained on a rotator in a Thermo Forma Stericult incubator (Marietta, OH) at 37°C for 5 hours. Ten µL of either plasma or brain homogenate and 50 µL of buffer were taken from the apparatus and added to silanized glass vials in a 96-well block containing 100 µL of acetonitrile fortified with internal standard. The samples were then vortexed, centrifuged and stored at -20°C prior to analysis. The unbound fractions determined from diluted brain tissue homogenates were corrected to yield an estimate of unbound fraction in the intact brain tissue using a previously published method (Kalvass and Maurer, 2002 ).
Brain Slices. After rats and mice were sacrificed in a CO 2 chamber, whole brain was obtained and immediately stored in ice-cold physiological buffer (122 mM NaCL, 25 mM NaHCO 3 , 10 mM glucose, 3 mM KCl, 1.4 mM CaCl 2 and 1.2 mM MgSO 4 pH 7.4, Ooie et al. 1997) . Cerebral cortex was dissected from whole brain and the hemispheres were separated. Coronal brain slices of the cortex (400 µm) were prepared using a McIlwain Tissue Chopper (Surrey, UK). The slices were immediately transferred to ice-cold buffer using a paintbrush to prevent injury to the slices.
One rat brain slice or 2 mouse brain slices were added to a silanized 25 mL scintillation vial containing either buffer or plasma spiked with 1 µg/mL of a test compound. The incubation was conducted on a rotator inside a Stericult incubator with 95%/5% O 2 /CO 2 and relative humidity of 75% at 37°C. At designated time points, 100 µL of incubation buffer or plasma was transferred to an eppendorf tube. The buffer eppendorf contained 100 µL of acetonitrile to wash the pipette tip Brain slices were homogenized in phosphate buffer at an approximately 40-fold dilution where the estimated brain slice weights were 25 mg and 12.5 mg for rat and mouse, respectively.
All incubation buffer, plasma and brain homogenate samples were diluted to the linear range of the standard curves and then precipitated with acetonitrile containing an internal standard followed by centrifugation at 3000 rpm for 10 minutes. The supernatant was then analyzed by HPLC/MS/MS for all except caffeine, theobromine and theophylline. The supernatant of these three compounds was dried down with N 2 at room temperature. The residual was reconstituted with 30-50 µL of acetonitrile, vortexed and underwent HPLC/MS/MS analysis.
The HPLC/MS/MS system consisted of either a Shimadzu ternary pump (Shimadzu LC-10A, Kyoto, Japan) or an Agilent quaternary pump HPLC system (Hewlett Packard, Palo Alto, CA), an autosampler and a PE Sciex API 3000 or 4000(Perkin-Elmer Sciex Instruments, Foster City, CA) mass spectrometer with a turbo ion spray interface (PE-Sciex, Thornhill, Ontario, Canada). Sample injection volume was 10 µl. HPLC/MS/MS conditions for the 13 compounds can be found in Table 1 . For all of the assays, the concentration of samples was within the linear range of quantitation. The relative accuracy was between 80% and 120%.
Protein normalization was performed to correct for dilution of brain homogenate. The Pierce BCA protein assay (Rockford, IL) was conducted on all of the brain homogenate samples. The weights of brain slices were calculated by comparing the protein concentration of the brain homogenate to a control brain homogenate containing a known weight of brain (Newman et al., 1995) .
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RESULTS
Optimization of brain slice uptake conditions. The effect of brain slice thickness on C slice /C plasma was evaluated in the present study. Using fluoxetine as a model substrate, the C slice /C plasma for slices with a thickness of 200, 300, 400, and 500 µm was similar after incubation for 6 hours. As some of the 200 µm and 300 µm slices appeared slightly damaged at the end of 6-hour incubation, 400 µm slices were used in the present study.
The time to reach equilibrium between the slices and incubation buffer and the slices and plasma was determined for eight model compounds; caffeine, CP-141938, fluoxetine, NFPS, propranolol, quinidine, theobromine, and theophylline. F u,slice decreased over time before reaching equilibrium between 1 and 6 hours. As representative examples, Figure 1A and 1C show the time course of f u,slice for caffeine and propranolol, respectively. Similarly, C slice /C plasma increased over time and reached equilibrium between 1 and 6 hours. Figure 1B and 1D show the time course of C slice /C plasma for caffeine and propranolol, respectively. For those compounds not extensively binding to brain tissue, such as caffeine, the equilibrium of brain slices and incubation medium can be achieved at one hour after incubation. However, for those compounds extensively binding to brain tissue, such as propranolol two to six hours were needed to achieve equilibrium.
The effect of fresh and previously frozen plasma on C slice /C plasma was examined using caffeine and fluoxetine as model compounds. The C slice /C plasma of caffeine was 0.364 ± 0.05 and 0.382 ± 0.03 in fresh plasma and previously frozen rat plasma, respectively. The C slice /C plasma of fluoxetine was 20.1 ± 2.9 and 20.6 ± 6.9 for fresh plasma and previously frozen plasma, respectively. No statistical difference was observed for the C slice /C plasma values of caffeine (p = 0.65) or fluoxetine (p = 0.91) between fresh and previously frozen plasma, indicating previously frozen plasma can be used for the brain slice uptake study. Table 2 and 3, respectively. All in vivo rat K p values calculated from the area under the curve (AUC) ratio of brain concentration and plasma concentration were obtained from previous studies . K p data for quinidine was from the literature (Kusuhara et al., 1997) . In vivo mouse K p values for NFPS, propranolol, theobromine, and theophylline were determined in the present study. All other mouse K p values were obtained from the literature (Smith et al., 2001; Doran et al., 2005) . All in vivo mouse K p values were calculated from the AUC ratio of brain concentration and plasma concentration.
Direct and indirect brain slice methods were evaluated. The in vitro and in vivo values were considered to be consistent if the values were within 3-fold. This criterion was chosen to allow for differences due to experimental error and for actual differences that would be considered to be of little pharmacologic consequence (Maurer et al., 2005) . The direct brain slice method uses C slice /C plasma to estimate K p,in . The relationship between rat K p and C slice /C plasma for the eight model compounds are exhibited in Figure 2A . Six of the eight model compounds, caffeine, fluoxetine, NFPS, propranolol, theobromine, and theophylline were non-P-gp substrates.
The C slice /C plasma values for the 6 non-P-gp substrates were within 3-fold of the observed in vivo K p . CP-141938 and quinidine were P-gp substrates. The C slice /C plasma values of CP-141938 and quinidine were 9 and 5 fold greater than their in vivo K p , respectively. The relationship between K p and C slice /C plasma in FVB mice and mdr1a/1b gene knockout mice for the eight model compounds are presented in Figure 3A and 3B, respectively. For the six non-P-gp substrates, the C slice /C plasma values were within 3-fold of the observed in vivo K p in FVB and mdr1a/1b knockout mice. The C slice /C plasma for the two P-gp substrates, quinidine and CP-141938, were 17-and 26-fold greater than the observed K p in FVB mice, respectively, but were within 3-fold of the observed K p in mdr1a/1b knockout mice. These results demonstrate that in rats and wild type mice, C slice /C plasma was consistent with the in vivo K p for non-P-gp substrates but over predicted the in vivo K p for Pgp substrates. In P-gp knockout mice, however, C slice /C plasma was consistent with K p for both non-P-gp and P-gp substrates.
The indirect slice method uses f u,plasma /f u,slice to predict K p,in . The relationship between rat K p and f u,plasma /f u,slice for the 8 model compounds is shown in Figure 2B for 5 of the 6 non-P-gp substrates were within 3-fold of the observed K p . Only NFPS showed 4-fold of difference between f u,plasma /f u,slice and K p . The f u,plasma /f u,slice for the two P-gp substrates, CP-141938 and quinidine, were 16-and 12-fold, respectively, greater than the K p . Therefore, both the direct and indirect brain slice methods were able to predict in vivo K p for non-P-gp substrates but over predicted P-gp substrates in P-gp competent animals.
Comparison of brain slices method and brain homogenate method. In order to compare the brain slice and brain homogenate methods, we used the brain homogenate method to examine the eight model compounds in rats. The relationship between K p and unbound fraction in plasma over the unbound fraction determined from brain homogenate ratio (f u,plasma /f u,homogenate ) for the eight model compounds is shown in Figure 2C . The f u,plasma /f u,homogenate for four of the six non-P-gp substrates(caffeine, fluoxetine, theobromine and theophylline) were within 3-fold of in vivo K p . However, the f u,plasma /f u,homogenate for 2 non-P-gp substrates, NFPS and propranolol, over predicted 27-fold and under predicted 4-fold the K p , respectively. The f u,plasma /f u,homogenate for the two P-gp substrates, CP-141938 and quinidine, were 8-fold and 9-fold, respectively, greater than the K p .
Furthermore, we selected additional five compounds, midazolam, 9-hydroxyrisperidone, sulpiride, thiopental, and zolpidem for which the brain homogenate method appeared unable to predict K p (Maurer et al., 2005) , to examine whether the brain slice method was able to better predict K p,in . The correlation between in vivo K p and C slice /C plasma and the correlation between in vivo K p and the f u,plasma /f u,homogenate in FVB and mdr1a/1b knockout mice is presented in Figure 4A and 4B, respectively. Midazolam, sulpiride, thiopental, and zolpidem were not P-gp substrates while 9-hydroxyrisperidone was a P-gp substrate. For these five compounds, f u,plasma /f u,homogenate over predicted the in vivo K p in FVB and mdr1a/1b knockout mice greater than 3-fold. However, C slice /C plasma was able to predict within 3-fold of the observed in vivo K p for thiopental in FVB and mdr1a/1b mice and for 9-hydroxyrisperidone in mdr1a/1b mice. For midazolam, zolpidem, and sulpiride, both methods were unable to predict in vivo K p within 3-fold. These results indicate the brain slice method is comparable to or slightly better than the brain homogenate method in predicting K p .
DISCUSSION
The objective of the present study was to assess the utility of brain slices to determine K p,in , a parameter dependent on nonspecific binding in brain tissue and plasma proteins. The main conclusions of this work are: 1) for 400 µm brain slices, the equilibrium can be achieved in six hours; 2) K p,in can be estimated from C slice /C plasma (direct brain slice method) or f u,plasma /f u,slice (indirect brain slice method) with 3-fold of error; 3) similar accuracy was observed between brain slice and brain homogenate methods.
Our study indicates that the optimal conditions for brain slice thickness and incubation time in the tissue binding study are 400 µm and six hours, respectively. Brain slices have been used to assess brain tissue binding in the literature (Van Peer et al., 1981) , where 1000-µm brain slices were incubated for one hour. The rate of diffusion and time to achieve equilibrium was a concern for that study. In order to address these issues, the effect of brain slice thickness and the duration of incubation were assessed.
Some of the brain slices with thickness less than 400 µm appeared to be damaged during the incubation process, therefore 400 µm brain slices were selected for all of the studies. For those compounds not extensively binding to brain tissue, such as caffeine the equilibrium of brain slices and the incubation medium was achieved at one hour after incubation. However, for those compounds extensively binding to brain tissue, such as propranolol, two to six hours were needed to achieve equilibrium. These observations are consistent with the literature. In a study of brain penetration for quinolone antimicrobial agents, the time to reach equilibrium for 300 µm brain slices was less than one hour (Ooie et al., 1997) . Similar equilibrium time was observed for 2-deoxyglucose in 540 µm brain slices (Newman et al., 1988) . In addition, for 300 µm brain slices, the equilibrium was achieved at two to six hours after incubation for propofol (Gredell et al., 2004) . In order to guarantee that equilibrium was achieved, all of our incubations were conducted for six hours. Our study also demonstrated that similar f u,slice and C slice /C plasma are observed in fresh prepared plasma and previously frozen plasma. Therefore, previously frozen plasma was also used in this study. 
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The present study indicates that brain slices can be used to determine the intrinsic brainplasma partition, K p,in . Direct and indirect brain slice methods have been examined to estimate K p,in . The direct brain slice method measures K p,in using the slice-plasma concentration ratio (C slice /C plasma ), which was obtained by incubation of brain slices in plasma. To our knowledge, this method represents a novel in vitro approach to estimate K p,in . This method was validated by the observation that in rats and wild type mice C slice /C plasma was consistent with the in vivo K p for non-P-gp substrates but over predicted the in vivo K p for P-gp substrates. In P-gp knockout mice C slice /C plasma was consistent with both non-P-gp and P-gp substrates. These results are expected from Equation 1. In wild type animals, K p,free is equal to unity for non-P-gp substrates and K p,free is less than unity for P-gp substrates, resulting in a K p,in equal to K p for non-P-gp substrates and a K p,in greater than K p for P-gp substrates assuming no other transporter is playing a significant role in brain penetration . In P-gp knockout animals, K p,free is equal to unity for both non-P-gp and P-gp substrates, resulting in a K p,in equal to K p for both non-P-gp and P-gp substrates.
The indirect brain slice method calculates K p,in from the ratio of f u,plasma /f u,slice , where f u,plasma and f u,slice are determined from equilibrium dialysis and the brain slice method, respectively. For non-P-gp substrates, f u,plasma /f u,slice was consistent with the in vivo observed K p but for P-gp substrates, f u,plasma /f u,slice was greater than the in vivo observed K p in rats. The direct and indirect brain slice methods appear to do equally well in estimating K p,in , but the direct method does not require the determination of f u,plasma .
Our study indicates there is an agreement between the brain slice and brain homogenate methods for K p,in prediction. The brain homogenate method has been reported in the literature to predict in vivo K p (Fichtl et al., 1991; Kalvass and Maurer, 2002; Maurer et al., 2005) . The homogenization process is of concern since it may alter binding properties by unmasking binding sites that are not accessible to a drug in intact brain tissue. Consequently, the reliability of calculating the unbound fraction in the intact brain tissue from the unbound fraction determined from a diluted brain tissue homogenate remains uncertain.
In addition, many lipophilic compounds in current CNS drug discovery programs often (Ward and Azzarano, 2004) . The indirect brain slice method offers an alternative and possibly more accurate approach to assess the unbound fraction in brain from intact brain tissue, as f u,slice . A brain slice maintains brain cellular structure but has no barrier between the incubation media and the tissues. Early studies demonstrated that BBB nonpermeable compounds, such as inulin, can penetrate into interstitial space in brain slice (Newman et al., 1988) . Consistent with this assertion, we have observed that there was no significant difference for brain uptake of P-gp substrates, CP-141938 and quinidine, in P-gp knockout and wild type mice brain slices although 50-and 36-fold differences were observed in their K p value in P-gp knockout and wild type mice. A brain slice incubation can be conducted in silanized glass vials and no dialysis membrane is involved, which further reduces the nonspecific adsorption for lipophilic compounds. The direct brain slice method further reduces the interference of adsorption and improves accuracy of the prediction by omitting the need to determine f u,plasma .
In rats, there was a good correlation between the in vivo K p and predicted using brain slice and brain homogenate methods for all model compounds except NFPS, whose f u,plasma /f u,homogenate was 27-fold lower than the observed K p while the direct and indirect brain slice method were within 3-fold and 4-fold of error, respectively. This discrepancy was due to the brain slice unbound fraction being approximately seven-fold greater than the value measured using brain homogenate. Whether the lower brain unbound fraction measured using the brain homogenate method was caused by greater access to binding sites normally inaccessible in intact brain tissue or non-specific binding to the dialysis apparatus remains to be determined.
In mice, the prediction using the direct brain slice method is consistent with that using the brain homogenate method. Both methods over-predicted the in vivo K p for midazolam, sulpiride, and zolpidem, indicating a mechanism other than P-gp mediated efflux transport may cause the lower brain penetration for this group of compounds. For thiopental and 9-hydroxyrisperidone the brain slice method appears to be in better agreement with K p . These results indicate the brain slice method is comparable to or probably slightly better than the brain homogenate method to There are at least two utilities of a brain slice technique to study brain penetration in CNS drug discovery setting. One is to determine if a compound having a low K p is due to low nonspecific binding in brain tissue relative to plasma proteins, i.e., low K p,in or due to an efflux transporter at the BBB, i.e., low K p,free . If the estimated K p,in of a compound is within 3-fold of the observed in vivo K p , the low in vivo K p is likely due to low binding in brain tissue relative to the plasma proteins indicating that brain penetration is not impaired. If the estimated K p,in of a compound is greater than 3-fold of the in vivo K p , the low K p is likely due to an efflux transporter at the BBB and the compound should be considered to have impaired brain penetration. In contrast to using in vitro techniques or transgenic animal models to assess if a specific transporter causes a low K p , the brain slice approach is a mechanism independent method. Therefore, it is useful in a CNS drug discovery program to screen out efflux transporter substrates. To elucidate the mechanism of impaired brain penetration, other in vitro and in vivo methods are needed to investigate the underlying mechanism of low BBB penetration.
The other utility is to use f u,slice and total in vivo brain concentration to estimate the brain interstitial fluid drug concentration or free brain concentration. This may be used as a surrogate approach in place of resource intensive brain microdialysis studies to estimate free brain concentration. The data from Ooie et al. (Ooie et al., 1997) supports this approach. The slice-tomedium concentration ratios for norfloxacin, ofloxacin, fleroxacin and pefloxacin were 1.9, 1.34, 1.3, and 1.3, respectively. The calculated f u,slice , the reciprocal of slice-to-medium ratios, are 0.5, 0.73, 0.8 and 0.75, respectively. They are within 3-fold of the observed in vivo f u,brain , 1.3, 0.57, 0.37, and 0.47, which were determined using brain microdialysis for each compound. Brain slices may represent a particularly useful approach in drug discovery to evaluate whether the lack of efficacy in an in vivo pharmacological model is due to insufficient free drug concentration in the brain. More studies are needed to assess the utilities of this application.
In conclusion, the present study demonstrates that the brain slice technique can be used to determine intrinsic brain to plasma partitioning determined solely by nonspecific binding to b (Smith et al., 2001) c (Maurer et al., 2005) This article has not been copyedited and formatted. The final version may differ from this version. 
